Treatment with denosumab reduces the incidence of new vertebral and hip fractures in postmenopausal women at high risk
Options
BORIS DOI
Publisher DOI
PubMed ID
21411557
Description
The FREEDOM (Fracture REduction Evaluation of Denosumab in Osteoporosis every 6 Months) trial showed denosumab significantly reduced the risk of fractures in postmenopausal women with osteoporosis.
Date of Publication
2011
Publication Type
Article
Language(s)
en
Contributor(s)
Boonen, S | |
Adachi, J D | |
Man, Z | |
Cummings, S R | |
Törring, O | |
Gallagher, J C | |
Farrerons, J | |
Wang, A | |
Franchimont, N | |
San Martin, J | |
Grauer, A | |
McClung, M |
Additional Credits
Series
Journal of clinical endocrinology and metabolism
Publisher
Endocrine Society
ISSN
0021-972X
Access(Rights)
restricted